Using iGlucose Device to Improve Blood Sugar Management in Pregnant Women with Diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of the iGlucose Remote Patient Monitoring Device in enhancing glycemic management for women with gestational diabetes or type 2 diabetes during pregnancy. By automating glucose monitoring data, the study aims to increase the number of recommended self-monitoring blood glucose (SMBG) checks and improve clinical outcomes. Participants will be women aged 18 and older who are diagnosed with gestational or type 2 diabetes before 30.6 weeks of pregnancy. The study employs a randomized controlled trial (RCT) design to assess the intervention's impact compared to routine care.

Why it matters

Who can join: the full rules

Inclusion Criteria

* All patients \>/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
* Non-anomalous singletons
* Ability to provide informed consent

Exclusion Criteria

* Patients with Type 1 diabetes
* Patients with fetal major congenital abnormalities
* Patients identified/referred after 30.6 weeks

Where it's running

• The University of Texas Health Science Center at Houston
  Houston, Texas, United States Recruiting

Study contacts

• Study coordinator: Joycelyn Corthwaite, RD
• Email: joycelyn.a.cornthwaite@uth.tmc.edu
• Phone: 832-325-7205

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Randomized comparison of immediate in-hospital 2-hour OGTT versus standard 4–12 week postpartum 2-hour OGTT for people with gestational diabetes

  This will test whether doing a 2-hour OGTT before hospital discharge gets more people who had gestational diabetes screened for diabetes than the usual 4–12 week outpatient test.

  Recruiting Ohio State University · Columbus, Ohio · NCT05909046

• Early Glucose Patterns in Pregnant Women at Risk for GDM

  This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.

  Recruiting DCB Research AG · Bern, Canton of Bern · NCT07783178

• Probiotic-augmented therapy for gestational diabetes

  This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.

  Recruiting Riphah International University · Rawalpindi, Punjab Province · NCT07645001

• Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes

  This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.

  Recruiting University of Tennessee Graduate School of Medicine · Knoxville, Tennessee · NCT07565727

• How sleep, lifestyle, and metabolism relate to pregnancy outcomes in gestational diabetes

  This project will see if sleep quality, anxiety, eating and activity habits, and metabolic markers relate to blood sugar control and birth outcomes in pregnant people with gestational diabetes.

  Recruiting University of Split, School of Medicine · Split · NCT07314944

• Pre-eclampsia risk in pregnancies after oocyte donation

  We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.

  Recruiting at 6 sites Copenhagen University Hospital, Hvidovre · Copenhagen and 5 other locations · NCT07263490

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.